Blog: VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01. Regulation FD Disclosure.

On September 22, 2022, the Company issued a press release entitled “Viveve to
Participate in Ladenburg Thalmann Healthcare Conference”. A copy of the
Company’s press release is furnished herewith as Exhibit 99.1 to this Current
Report on Form 8-K and incorporated herein by reference.

The information in Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or otherwise subject to the liabilities of that
Section, nor shall it be deemed subject to the requirements of amended Item 10
of Regulation S-K, nor shall it be deemed incorporated by reference into any
filing of the Company under the Securities Act of 1933, as amended, or the
Exchange Act, whether made before or after the date hereof, regardless of any
general incorporation language in such filing. The furnishing of this
information hereby shall not be deemed an admission as to the materiality of any
such information.

--------------------------------------------------------------------------------

Item 9.01.  Financial Statements and Exhibits.



(d) Exhibits

Exhibit
  No.     Description

99.1        Press Release issued by the Company on September 22, 2022, furnished
          herewith.

104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)



——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s